tradingkey.logo


tradingkey.logo


Bionano Genomics Inc

BNGO
1.125USD
-0.025-2.17%
終倀 03/30, 16:00ET15分遅れの株䟡
17.80K時䟡総額
損倱額盎近12ヶ月PER


Bionano Genomics Inc

1.125
-0.025-2.17%

詳现情報 Bionano Genomics Inc 䌁業名

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Incの䌁業情報


䌁業コヌドBNGO
䌚瀟名Bionano Genomics Inc
䞊堎日Aug 01, 2018
最高経営責任者「CEO」Holmlin (R. Erik)
埓業員数98
蚌刞皮類Ordinary Share
決算期末Aug 01
本瀟所圚地9540 Towne Centre Drive
郜垂SAN DIEGO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号92121
電話番号18588887600
りェブサむトhttps://bionano.com/
䌁業コヌドBNGO
䞊堎日Aug 01, 2018
最高経営責任者「CEO」Holmlin (R. Erik)

Bionano Genomics Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
362.00
-5.52%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
261.00
-1.15%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.92%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-535.29%
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Jonathan Dixon, J.D.
Mr. Jonathan Dixon, J.D.
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
362.00
-5.52%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
261.00
-1.15%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.92%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-535.29%
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
事業別USD
䌚瀟名
収益
比率
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%
地域別USD
䌚瀟名
収益
比率
EMEIA
3.63M
49.30%
Americas
2.85M
38.62%
Asia Pacific
890.00K
12.08%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%

株䞻

曎新時刻: Fri, Feb 27
曎新時刻: Fri, Feb 27
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Lincoln Alternative Strategies LLC
4.73%
GSA Capital Partners LLP
3.05%
Abbe (Richard)
2.91%
Iroquois Capital Management, LLC
1.75%
DRW Securities, LLC
1.52%
他の
86.04%
株䞻統蚈
株䞻統蚈
比率
Lincoln Alternative Strategies LLC
4.73%
GSA Capital Partners LLP
3.05%
Abbe (Richard)
2.91%
Iroquois Capital Management, LLC
1.75%
DRW Securities, LLC
1.52%
他の
86.04%
皮類
株䞻統蚈
比率
Hedge Fund
5.62%
Corporation
4.73%
Investment Advisor
3.03%
Individual Investor
2.93%
Investment Advisor/Hedge Fund
0.79%
Research Firm
0.29%
他の
82.61%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Lincoln Alternative Strategies LLC
525.00K
5.16%
+525.00K
--
Sep 17, 2025
Abbe (Richard)
322.53K
3.17%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.91%
+194.66K
--
Sep 30, 2025
The Vanguard Group, Inc.
50.46K
0.5%
+50.46K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
26.84K
0.26%
+7.97K
+42.22%
Sep 30, 2025
Carret Asset Management, LLC
25.00K
0.25%
+25.00K
--
Sep 30, 2025
Two Sigma Investments, LP
15.58K
0.15%
+15.58K
--
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
比率0%
Avantis US Small Cap Equity ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
日付
配圓萜ち日
皮類
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI
î™